Growing Placenta-Generating Cells

Researchers derive trophoblast stem cells from mouse fibroblasts, paving the way for cell therapy for placental dysfunction diseases.

Written byJef Akst
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

High-magnification micrograph of intermediate trophoblast cellsWIKIMEDIA, NEPHRONTransiently expressing three genes in mouse fibroblasts, an international team of researchers has coaxed the cells into trophoblast stem-like cells (TSCs), skipping a pluripotent stage. The derived cells had similar characteristics to blastocyst-derived TSCs—which form most of the developing placenta—and contributed to placental cell lineages in vitro, according to a study published last month (September 24) in Cell Stem Cell.

“Here, we describe a method to generate stable and fully functional TSC-like cells from murine fibroblasts by transient ectopic expression of three TSC key master regulators, Gata3, Eomes, and Tfap2c,” the authors wrote in their paper. “These data suggest that the conversion of fibroblasts into iTSCs represents a very high degree of nuclear reprogramming and refute the hypothesis that complete nuclear reprogramming can be achieved only in cells undergoing conversion to ESC-like cells.”

“The success of this study will grant a real chance for women who suffer from placental dysfunction diseases to have healthy babies,” according to a press release. When the placenta does not develop properly or is damaged, the baby be born prematurely, have a low birth weight, or have other complications that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies